1. Committee on Quality of HealthCare in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st century. Washington D.C.: National Academies Press; 2001.
2. Partnership for Solutions. Chronic Conditions: Making the Case for Ongoing Care: Robert Wood Johnson Foundation; 2002.
3. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–74. [PubMed] 4. Ben-Noun L. Characteristics of comorbidity in adult asthma. Public Health Rev. 2001;29(1):49–61. [PubMed] 5. Sokal J, Messias E, Dickerson FB, Kreyenbuhl J, Brown CH, Goldberg RW. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421–7. [PubMed] 6. Tellez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 2005;46(12):1955–62. [PubMed] 7. Wolff JL, Starfield B, Anderson GF. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–76. [PubMed] 8. John R, Kerby DS, Hennessy CH. Patterns and impact of comorbidity and multimorbidity among community-resident American Indian elders. Gerontologist 2003;43(5):649–60. [PubMed] 9. Park YW, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163(4):427–36. [PubMed]
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. J Am Med Assoc. 2002;287(3):356–9.
11. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433–8. [PubMed] 12. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164(10):1066–76. [PubMed] 13. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288(21):2709–16. [PubMed] 14. Guettier JM, Georgopoulos A, Tsai MY, et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab. 2005;90(3):1705–11. [PubMed] 15. Wyszynski DF, Waterworth DM, Barter PJ, et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005;95(2):194–8. [PubMed] 16. Dunlop DD, Lyons JS, Manheim LM, Song J, Chang RW. Arthritis and heart disease as risk factors for major depression: the role of functional limitation. Med Care. 2004;42(6):502–11. [PubMed] 17. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: The Women’s Health and Aging Study. J Clin Epidemiol. 1999;52(1):27–37. [PubMed] 18. Fultz NH, Ofstedal M, Herzog AR, Wallace RB. Additive and interactive effects of comorbid physical and mental conditions on functional health. J Aging Health. 2003;15(3):465–84. [PubMed] 19. Lee TA, Pickard AS, Bartle B, Weiss KB. Osteoarthritis: a comorbid marker for longer life? Ann Epidemiol. 2007;17:380–4. [PubMed]
20. National Academy of Social Insurance. Medicare in the 21st Century: Building a Better Chronic Care System. Washington, DC: National Academy of Social Insurance; 2003.
21. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. J Am Med Assoc. 2005;294(6):716–24.
22. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64. [PubMed]
23. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Assoc. 2003;289(9):1107–16.
24. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870–4. [PubMed] 25. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171–80. [PubMed] 26. Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. Br Med J 2003;327(7419):837. [PMC free article] [PubMed] 27. Anderson GF. Physician, public, and policymaker perspectives on chronic conditions. Arch Intern Med. 2003;163:437–42. [PubMed] 28. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338(21):1516–20. [PubMed] 29. Nutting PA, Rost K, Smith J, Werner JJ, Elliot C. Competing demands from physical problems. Arch Fam Med 2000;9:1059–64. [PubMed]
30. Ware MG, Flavell CM, Lewis EF, Nohria A, Warner-Stevenson L, Givertz MM. Heart failure and diabetes: collateral benefit of chronic disease management. Prev Manag Congest Heart Fail 2006;12(3):132–6.
31. Harman JS, Edlund MJ, Fortney JC, Kallas H. The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans. J Am Geriatr Soc 2005;53(12):2178–83. [PubMed]
32. Harpole LH, Williams JW Jr, Olsen MK, et al. Improving depression outcomes in older adults with comorbid medical illness. Gen Hosp Psych 2005;27(1):4–12.
33. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1126–33.
34. Kruzikas DT, Jiang HJ, Remus D, Barrett ML, Coffey RM, Andrews R. Preventable Hospitalizations: A Window into Primary and Preventive Care, 2000. Washington, DC: Agency for Healthcare Research and Quality; 2004.
35. Min LC, Reuben DB, MacLean CH, et al. Predictors of overall quality of care provided to vulnerable older people. J Am Geriatr Soc. 2005;53(10):1705–11. [PubMed] 36. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45. [PubMed] 37. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 2006;145(9):646–53. [PubMed] 38. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Quarterly 1996;74:511–44. [PubMed]
39. Smith C, Cowan C, Sensenig A, Catlin A. Health Accounts Team. Health spending growth slows in 2003. Health Affairs 2005;24(1):184–94.
40. Congressional Budget Office. High Cost Medicare Beneficiaries. Washington, DC: The Congress of the United States; 2005.
41. Niefeld M, Braunstein JB, Wu AW, Saudek CD, Weller W, Anderson GF. Preventable hospitalization among elderly Medicare beneficiaries with Type 2 diabetes. Diabetes Care 2003;26(5):1344–9. [PubMed] 42. Himelhoch S, Weller W, Wu AW, Anderson GF, Cooper LA. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 2004;42(6):512–21. [PubMed] 43. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157(1):99–104. [PubMed]
44. Center on an Aging Society. Disease management programs: Improving health while reducing costs? Washington, DC: Georgetown University; 2004.
45. Smith V, Ramesh R, Gifford K, Ellis E, Wachino V. States Respond to Fiscal Pressure: State Medicaid Spending Growth and Cost Containment in Fiscal Years 2004 and 2005: Results from a 50-state Survey. Washington, DC: The Henry J. Kaiser Family Foundation; 2004.
46. Sprague L. Disease Management to Population-Based Health: Steps in the Right Direction? National Health Policy Forum Issue Brief 2003;791:1–16.
47. Glendinning D. New Medicare demo project focuses on chronic health care. American Medical News 2005;Government & Medicine:5, 8.
48. Gold M, Lake T, Black WE, Smith M. Challenges in improving care for high-risk seniors in Medicare: lessons and observations from past field demonstrations. Health Affairs 2005;Web Exclusive(26 April):W5-199–W5-211.
49. Congressional Budget Office. An Analysis of the Literature on Disease Management Programs. Washington, DC: Congressional Budget Office; 2004 October 13.
50. Short AC, Mays GP, Mittler J. Disease Management: A Leap of Faith to Lower-Cost, Higher-Quality Health Care. HSC Issue Brief 2003;No. 69.
51. Bodenheimer T. Disease management in the American market. Br Med J 2000;320:563–6. [PMC free article] [PubMed] 52. Goetzel R, Ozminkowski R, Villagra V, Duffy J. Return on investment in disease management: A review. Health Care Financ Rev 2005;26:1–19. [PubMed]
53. Blumenthal D, Beeuwkes Buntin M. Carve-outs for Medicare: Possible benefits and risks. In: Reischauer RD, Butler S, Lave JR, eds. Medicare: Preparing for the Challenges of the 21st Century. Washington, DC: National Academy of Social Insurance; 1998:152–83.
54. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997;127(12):1097–102. [PubMed]
55. Mays GP, Claxton G, White J. Managed care rebound? Recent changes in health plans’ cost containment strategies. Health Affairs 2004;Web Exclusive(W4):427–36.